● Recruiting

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

Condition: Ocular Myasthenia Gravis · Sponsor: Tang-Du Hospital

PhaseN/A

Planned participants200

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study collects the clinical data of new-onset ocular myasthenia gravis (OMG) patients, assesses outcomes and adverse effects of different treatment options, and evaluate risk factors of conversion to generalized MG(GMG).

This description comes directly from the study's public registry record.

Talk to the study team

Jun Guo, M.D. · 86-29-8477 8844 · guojun_81@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Tangdu Hospotal

Xi'an, Shaanxi, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04182984